South San Francisco, CA, United States of America

Kevin Holden

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Kevin Holden

Introduction

Kevin Holden is a notable inventor based in South San Francisco, California, known for his innovative contributions in the field of fatty acid derivatives. With a total of four patents to his name, Holden has made significant strides in biotechnology and enzymatic processes, enhancing production methods that hold great potential in various industries.

Latest Patents

Holden's most recent patents include groundbreaking technologies related to fatty acid derivatives. The first patent focuses on the production of fatty acid derivatives using engineered recombinant host cells, which are designed to produce these compositions with higher titer, yield, or productivity compared to non-engineered counterparts. The compositions encompass a wide array of fatty compounds, including fatty acids, fatty alcohols, fatty aldehydes, fatty esters, alkanes, terminal olefins, internal olefins, and ketones.

Another significant patent involves enzyme variants that demonstrate improved ester synthase properties for the generation of fatty acid esters. This innovation extends to recombinant host cells expressing such variants, alongside the cell cultures and fatty acid ester compositions produced by these engineered cells.

Career Highlights

Throughout his career, Kevin Holden has made impactful contributions while working with leading companies in biotechnology. Notably, he has been associated with Genomatica, Inc. and Ls9, Inc., where he has played a vital role in advancing bioprocessing technologies and enzyme engineering. His work emphasizes enhancing the productivity and efficiency of biochemical production methods.

Collaborations

In his professional journey, Holden has collaborated with talented individuals such as Tarah S Baron and Bernardo M Da Costa. These partnerships have facilitated the exchange of knowledge and expertise, contributing to innovative developments in their field.

Conclusion

Kevin Holden continues to be an influential figure in the realm of biotechnology, leveraging his expertise to drive forward advancements in fatty acid derivatives and enzymatic processes. His patents not only reflect his inventive spirit but also signify his commitment to creating sustainable and efficient production methods in the industry. As he progresses in his career, the impact of his work is likely to resonate across multiple sectors, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…